Zentalis Pharmaceuticals Quote - ZNTL

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

4.31

Bid

4.04

Ask

4.59

Volume

559,965

4.17 Day's Range 4.46

3.27 52 Week Range 29.03

Market Cap

306.067M

Previous Close

4.31

Open

4.29

Last Trade

283

4.31

(formt)

Last Trade Time

15:19:03

Financial Volume

US$ 2,433,811

VWAP

4.3464

Average Volume (3m)

1,445,368

Shares Outstanding

71,013,233

Dividend Yield

PE Ratio

-1.07

Earnings Per Share (EPS)

-4.11

Revenue

Net Profit

-292.19M

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It uses a drug discovery engine, which it refers to as Integrated Discovery Engine, to identify targets a... Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It uses a drug discovery engine, which it refers to as Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believes could result in potentially differentiated product profiles. It has two lead product candidates under pipeline: ZN-c5, for the treatment of advanced estrogen receptor-positive, human epidermal growth factor receptor 2-negative, or ER+/HER2-, advanced or metastatic breast cancer; and ZN-c3, for the treatment of advanced solid tumors as monotherapy and ovarian cancer. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.zentalis.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Zentalis Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ZNTL. The last closing price for Zentalis Pharmaceuticals was US$4.31. Over the last year, Zentalis Pharmaceuticals shares have traded in a share price range of US$ 3.27 to US$ 29.03.

Zentalis Pharmaceuticals currently has 71,013,233 shares outstanding. The market capitalization of Zentalis Pharmaceuticals is US$306.07 million. Zentalis Pharmaceuticals has a price to earnings ratio (PE ratio) of -1.07.

Period †	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.02	0.4662004662	4.29	4.58	3.59	750359	3.98738949	CS
4	0.11	2.61904761905	4.2	4.79	3.27	1125661	4.0503344	CS
12	-7.57	-63.7205387205	11.88	13.24	3.27	1445368	6.01441121	CS
26	-8.92	-67.4225245654	13.23	18.07	3.27	1102828	9.07862789	CS
52	-21.38	-83.223043986	25.69	29.03	3.27	983346	12.39065088	CS
156	-46.65	-91.5423861852	50.96	87.19	3.27	704897	22.52350716	CS
260	-20.38	-82.5435398947	24.69	87.19	3.27	571189	25.8562061	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
HBPHelix BioPharma Corp	$ 0.27 (20.00%)	5.31k
APLIAppili Therapeutics Inc	$ 0.035 (16.67%)	23k
DRTDIRTT Environmental Solutions Ltd	$ 0.61 (10.91%)	35.3k
LAMLaramide Resources Ltd	$ 0.64 (10.34%)	120.65k
ESPBrompton Energy Split Corp	$ 4.47 (10.10%)	400
KRNKarnalyte Resources Inc	$ 0.115 (-17.86%)	26.86k
HUTHut 8 Corp	$ 20.45 (-17.81%)	1.39M
GMTNGold Mountain Mining Corp	$ 0.03 (-14.29%)	30.36k
SAUSt Augustine Gold and Copper Limited	$ 0.065 (-13.33%)	55k
YRBYorbeau Resources Inc	$ 0.035 (-12.50%)	1.04k
RYRoyal Bank of Canada	$ 151.57 (-0.42%)	19.1M
BNSBank of Nova Scotia	$ 62.97 (-0.35%)	8.59M
BMOBank of Montreal	$ 120.25 (0.92%)	8.39M
VRNVeren Inc	$ 10.23 (-2.48%)	6.49M
TDToronto Dominion Bank	$ 80.05 (0.87%)	5.91M